Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Showing results for hiv reservoir. Search instead for hivreservoir (1 item)

Results: 1 to 20 of 1428

1.

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-Carbonell D, Garcia-Mesa Y, Karn J, Mo X, Khalili K.

Proc Natl Acad Sci U S A. 2014 Jul 21. pii: 201405186. [Epub ahead of print]

PMID:
25049410
[PubMed - as supplied by publisher]
2.

Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases.

Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR.

Ann Intern Med. 2014 Jul 22. doi: 10.7326/M14-1027. [Epub ahead of print]

PMID:
25047577
[PubMed - as supplied by publisher]
3.

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.

Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, Del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, Contijoch E, Todd JP, Silvestri G, Nason M, Norgren Jr RB, Keele BF, Rao S, Langer JA, Lifson JD, Schreiber G, Douek DC.

Nature. 2014 Jul 9. doi: 10.1038/nature13554. [Epub ahead of print]

PMID:
25043006
[PubMed - as supplied by publisher]
4.

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.

Whitney JB, Hill AL, Sanisetty S, Penaloza-MacMaster P, Liu J, Shetty M, Parenteau L, Cabral C, Shields J, Blackmore S, Smith JY, Brinkman AL, Peter LE, Mathew SI, Smith KM, Borducchi EN, Rosenbloom DI, Lewis MG, Hattersley J, Li B, Hesselgesser J, Geleziunas R, Robb ML, Kim JH, Michael NL, Barouch DH.

Nature. 2014 Jul 20. doi: 10.1038/nature13594. [Epub ahead of print]

PMID:
25042999
[PubMed - as supplied by publisher]
5.

HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).

Boullé C, Rouet F, Fassinou P, Msellati P, Debeaudrap P, Chaix ML, Rouzioux C, Avettand-Fenoel V.

J Antimicrob Chemother. 2014 Jul 17. pii: dku274. [Epub ahead of print]

PMID:
25038068
[PubMed - as supplied by publisher]
6.

In vivo Evaluation of Self Emulsifying Drug Delivery System for Oral Delivery of Nevirapine.

Chudasama AS, Patel VV, Nivsarkar M, Vasu KK, Shishoo CJ.

Indian J Pharm Sci. 2014 May;76(3):218-24.

PMID:
25035533
[PubMed]
Free PMC Article
7.

CD8 cells maintain suppression of simian immunodeficiency virus in the central nervous system.

Marcondes MC, Morsey B, Emanuel K, Lamberty BG, Flynn CT, Fox HS.

J Infect Dis. 2014 Jul 17. pii: jiu401. [Epub ahead of print]

PMID:
25035516
[PubMed - as supplied by publisher]
8.

Microdevices for examining immunological responses of single cells to HIV.

Choi J, Jeong Y, Lee KH.

Biosci Rep. 2014 Jul 16. [Epub ahead of print]

PMID:
25028990
[PubMed - as supplied by publisher]
Free Article
9.

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW.

AIDS. 2014 Jul 14. [Epub ahead of print]

PMID:
25022595
[PubMed - as supplied by publisher]
10.

Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.

Wang S, Rong L.

J Theor Biol. 2014 Jul 10. pii: S0022-5193(14)00393-2. doi: 10.1016/j.jtbi.2014.06.042. [Epub ahead of print]

PMID:
25016044
[PubMed - as supplied by publisher]
11.

Immunologic strategies for HIV-1 remission and eradication.

Barouch DH, Deeks SG.

Science. 2014 Jul 11;345(6193):169-74. doi: 10.1126/science.1255512.

PMID:
25013067
[PubMed - in process]
12.

CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals.

Kared H, Saeed S, Klein MB, Shoukry NH.

PLoS One. 2014 Jul 9;9(7):e101441. doi: 10.1371/journal.pone.0101441. eCollection 2014.

PMID:
25007250
[PubMed - in process]
Free PMC Article
13.

Long-term Antiretroviral Treatment Initiated in Primary HIV-1 Infection Affects the Size, Composition and Decay Kinetics of the Reservoir of HIV-1 Infected CD4 T Cells.

Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M.

J Virol. 2014 Jun 25. pii: JVI.01046-14. [Epub ahead of print]

PMID:
24965451
[PubMed - as supplied by publisher]
14.

Differentiation of IL-17-Producing Effector and Regulatory Human T Cells from Lineage-Committed Naive Precursors.

Mercer F, Khaitan A, Kozhaya L, Aberg JA, Unutmaz D.

J Immunol. 2014 Aug 1;193(3):1047-54. doi: 10.4049/jimmunol.1302936. Epub 2014 Jun 23.

PMID:
24958901
[PubMed - in process]
15.

Decreased HIV Type 1 Transcription in CCR5-Δ32 Heterozygotes During Suppressive Antiretroviral Therapy.

Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK.

J Infect Dis. 2014 Jun 16. pii: jiu338. [Epub ahead of print]

PMID:
24935955
[PubMed - as supplied by publisher]
16.

Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Yen PJ, Mefford ME, Hoxie JA, Williams KC, Desrosiers RC, Gabuzda D.

Virology. 2014 Jun;458-459:53-68. doi: 10.1016/j.virol.2014.03.024. Epub 2014 May 8.

PMID:
24928039
[PubMed - in process]
Free Article
17.

Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance.

Guo D, Zhang G, Wysocki TA, Wysocki BJ, Gelbard HA, Liu XM, McMillan JM, Gendelman HE.

J Virol. 2014 Jun 11. pii: JVI.01557-14. [Epub ahead of print]

PMID:
24920821
[PubMed - as supplied by publisher]
Free Article
18.

Early Initiation of Combination Antiretroviral Therapy in HIV-1-Infected Newborns Can Achieve Sustained Virologic Suppression With Low Frequency of CD4+ T Cells Carrying HIV in Peripheral Blood.

Bitnun A, Samson L, Chun TW, Kakkar F, Brophy J, Murray D, Justement S, Soudeyns H, Ostrowski M, Mujib S, Harrigan PR, Kim J, Sandstrom P, Read SE.

Clin Infect Dis. 2014 Jun 9. pii: ciu432. [Epub ahead of print]

PMID:
24917662
[PubMed - as supplied by publisher]
19.

Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.

Torres-Cornejo A, Benmarzouk-Hidalgo O, Gutierrez-Valencia A, Ruiz-Valderas R, Viciana P, López-Cortés L.

HIV Med. 2014 Jun 9. doi: 10.1111/hiv.12170. [Epub ahead of print]

PMID:
24913409
[PubMed - as supplied by publisher]
20.

The variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an HIV-1 strain.

Xiang Y, Liu W, Chen Y, Zhang C, Su W, Zhang Y, Sun J, Gao F, Jiang C.

PLoS One. 2014 Jun 4;9(6):e98058. doi: 10.1371/journal.pone.0098058. eCollection 2014.

PMID:
24897520
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk